A trivalent vaccine (Fluad) for the prevention of seasonal influenza in people ages 65 years and older. ... In a trial of 7,082 older participants, the new vaccine and an existing one (Agriflu) induced comparable antibody levels.
A vaccine (Trumenba) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in patients 10 through 25 years. ... Previously, FDA-approved meningococcal vaccines only covered serogroups A, C, Y, and W.
Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. ... In a trial, the vaccine was 83.8% effective in preventing influenza compared to placebo.
https://acpinternist.org/archives/2018/02/qi-project-helps-raise-vaccination-rates.htm. With patients likely to decline all vaccinations, of any kind, due mainly to concerns about safety or adverse ... all vaccinations, of any kind, due mainly to
The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends hepatitis B vaccination for all adults ages 19 to 59 years and those ages 60 years and older with risk ... The ACIP previously recommended hepatitis B vaccination of children,
We could obviously do that and more of it, both with influenza vaccine and other vaccines. ... Q: Are there any other vaccines, like the shingles vaccine, that are underutilized?
an adequate immune response to COVID-19 vaccines, or have a history of severe adverse reactions to a COVID-19 vaccine and/or its components. ... Revisions to the Johnson & Johnson (Janssen) COVID-19 vaccine fact sheets for vaccination providers and
That's why, in August, ACIP recommended an additional vaccine dose for immunocompromised patients. ... ACIP experts also considered the downsides of more shots, which include even less likelihood of vaccination among the vaccine-hesitant, who may see
An expansion of approval for the Zostavax vaccine, for the prevention of shingles in individuals 50 to 59 years of age. ... The vaccine was already approved for use in individuals 60 years of age and older.
Vaccines for the 2010-2011 influenza season in the United States, which contain three strains: A/California/7/09 (H1N1)-like virus (pandemic [H1N1] 2009 influenza virus), A/Perth /16/2009